Back to Search
Start Over
Table S2 from Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Summary of BH3 profiling for PBMC samples collected at baseline.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....875185de9f18254bdd2b7da2234764bc
- Full Text :
- https://doi.org/10.1158/1078-0432.22841372